How I Treat Follicular Lymphoma
Jonathan W. Friedberg, MD, University of Rochester
Saturday, September 9, 2017 8:10 a.m.
Fairmont Chicago, Millennium Park, Chicago, IL
Improvements in both therapy and supportive care have allowed the median overall survival for patients diagnosed with advanced stage follicular lymphoma to exceed 20 years; however, a subset of patients exists with less favorable outcomes. This session will review treatment options for patients with early and advanced stage follicular lymphoma, and address how and when novel agents should be introduced into the paradigm. The focus will be on a “precision approach” to ensure patients are not over- or under-treated.
About the Speaker
Jonathan W. Friedberg, MD, is Samuel Durand Professor of Medicine at the University of Rochester and Director of the James P. Wilmot Cancer Institute. He received his medical degree from Harvard Medical School, and his postgraduate training included an internship and residency at Massachusetts General Hospital. Dr. Friedberg completed a medical oncology and hematology fellowship at Dana-Farber/Partners Cancer Care in Boston. Dr. Friedberg also has an MMSc degree from Harvard Medical School in clinical investigation. His research interests focus on development of novel therapies for patients with lymphoma. He is chair of the lymphoma committee in the SWOG NCTN group, and serves as associate editor for hematological malignancies at Journal of Clinical Oncology. He was awarded the Scholar in Clinical Research award from the Leukemia & Lymphoma Society. Dr. Friedberg has chaired the Education Program of the American Society of Hematology annual meeting.
back to top